Home:
PCU 4|2002:
Peter
T Scardino, MD:
Select publications
Select publications
Bolla M et al. Improved survival in patients with locally
advanced prostate cancer treated with radiotherapy and goserelin.
N Engl J Med 1997;337:295-300. Abstract
Bolla M et al. Long-term results with immediate androgen
suppression and external irradiation in patients with locally advanced
prostate cancer (an EORTC study): A phase III randomised trial.
Lancet 2002;360(9327):103-6. Abstract
Catton C et al. Adjuvant and salvage radiation therapy
after radical prostatectomy for adenocarcinoma of the prostate.
Radiother Oncol 2001;59(1):51-60. Abstract
Do LV et al. Postoperative radiotherapy for carcinoma
of the prostate: Impact on both local control and distant disease-free
survival. Am J Clin Oncol 2002;25(1):1-8. Abstract
Grossfeld GD et al. Management of a positive surgical
margin after radical prostatectomy: Decision analysis. J
Uro 2000;164(1):93-9. Abstract
Iversen P et al. Bicalutamide monotherapy compared with
castration in patients with nonmetastatic locally advanced prostate
cancer: 6.3 years of follow-up. J Urol 2000;164:1579-82.
Abstract
The Medical Research Council Prostate Cancer Working Party
Investigator Group. Immediate versus deferred treatment for advanced
prostatic cancer: Initial results of the Medical Research Council
trial. Br J Urol 1997;79:235-46. Abstract
Messing EM et al. Immediate hormonal therapy compared
with observation after radical prostatectomy and pelvic lymphadenectomy
in men with node-positive prostate cancer. New Engl J Med
1999;341:1781-8. Abstract
Oosterlinck W et al. Tolerability and safety of flutamide
in monotherapy, with orchiectomy or with LHRHa in advanced prostate
cancer patients. A Belgian multicenter study of 905 patients. Eur
Urol 1996;30(4):458-63. Abstract
Schroder FH et al. Prostate cancer treated by antiandrogens:
Is sexual function preserved? EORTC Genitourinary Group. European
Organization for Research and Treatment of Cancer. Br J
Cancer 2000;82(2):283-90. Abstract
See WA et al. Bicalutamide as immediate therapy either
alone or as adjuvant to standard care of patients with localized
or locally advanced prostate cancer: First analysis of the early
prostate cancer program. J Urol 2002;168(2):429-35. Abstract
Tyrrell CJ et al. A randomised comparison of 'Casodex'
(bicalutamide) 150 mg monotherapy versus castration in the treatment
of metastatic and locally advanced prostate cancer. Eur
Urol 1998;33(5):447-56. Abstract
|
